Exelixis
EXEL
#1851
Rank
$11.05 B
Marketcap
$41.25
Share price
-0.10%
Change (1 day)
5.34%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company